309 related articles for article (PubMed ID: 35062310)
1. The
Urda L; Kreuter MH; Drewe J; Boonen G; Butterweck V; Klimkait T
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062310
[TBL] [Abstract][Full Text] [Related]
2. Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses
Stone NE; Jaramillo SA; Jones AN; Vazquez AJ; Martz M; Versluis LM; Raniere MO; Nunnally HE; Zarn KE; Nottingham R; Ng KR; Sahl JW; Wagner DM; Knudsen S; Settles EW; Keim P; French CT
mBio; 2021 Jan; 12(1):. PubMed ID: 33468703
[TBL] [Abstract][Full Text] [Related]
3. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
Stegmann KM; Dickmanns A; Gerber S; Nikolova V; Klemke L; Manzini V; Schlösser D; Bierwirth C; Freund J; Sitte M; Lugert R; Salinas G; Meister TL; Pfaender S; Görlich D; Wollnik B; Groß U; Dobbelstein M
Virus Res; 2021 Sep; 302():198469. PubMed ID: 34090962
[TBL] [Abstract][Full Text] [Related]
4. Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.
Nair MS; Huang Y; Fidock DA; Polyak SJ; Wagoner J; Towler MJ; Weathers PJ
J Ethnopharmacol; 2021 Jun; 274():114016. PubMed ID: 33716085
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.
Jang Y; Shin JS; Lee MK; Jung E; An T; Kim UI; Kim K; Kim M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557278
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of SARS-CoV-2 infection and replication by Petasites hybridus CO2-extract (Ze 339).
Jakwerth CA; Grass V; Erb A; Pichlmair A; Boonen G; Butterweck V; Schmidt-Weber CB
Biomed Pharmacother; 2024 Jan; 170():115959. PubMed ID: 38061134
[TBL] [Abstract][Full Text] [Related]
7. Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication.
Pirzada RH; Haseeb M; Batool M; Kim M; Choi S
Cells; 2021 Apr; 10(5):. PubMed ID: 33946869
[TBL] [Abstract][Full Text] [Related]
8. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M
Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of itraconazole against SARS-CoV-2.
Van Damme E; De Meyer S; Bojkova D; Ciesek S; Cinatl J; De Jonghe S; Jochmans D; Leyssen P; Buyck C; Neyts J; Van Loock M
J Med Virol; 2021 Jul; 93(7):4454-4460. PubMed ID: 33666253
[TBL] [Abstract][Full Text] [Related]
10. A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation.
Kotaki T; Xie X; Shi PY; Kameoka M
Sci Rep; 2021 Jan; 11(1):2229. PubMed ID: 33500537
[TBL] [Abstract][Full Text] [Related]
11. Extract matrix composition does not affect in vitro leukotriene inhibitory effects of the Petasites hybridus extract Ze 339.
Kodjadjiku U; Nägele B; Halbsguth C; Butterweck V
Fitoterapia; 2021 Sep; 153():104986. PubMed ID: 34252512
[TBL] [Abstract][Full Text] [Related]
12. Antiviral effects of human placenta hydrolysate (Laennec
Kim EH; Kim YI; Jang SG; Im M; Jeong K; Choi YK; Han HJ
J Microbiol; 2021 Nov; 59(11):1056-1062. PubMed ID: 34613605
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro.
Raymonda MH; Ciesla JH; Monaghan M; Leach J; Asantewaa G; Smorodintsev-Schiller LA; Lutz MM; Schafer XL; Takimoto T; Dewhurst S; Munger J; Harris IS
Virology; 2022 Jan; 566():60-68. PubMed ID: 34871905
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease.
van de Sand L; Bormann M; Alt M; Schipper L; Heilingloh CS; Steinmann E; Todt D; Dittmer U; Elsner C; Witzke O; Krawczyk A
Viruses; 2021 Apr; 13(4):. PubMed ID: 33918301
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes.
Choi SW; Shin JS; Park SJ; Jung E; Park YG; Lee J; Kim SJ; Park HJ; Lee JH; Park SM; Moon SH; Ban K; Go YY
Antiviral Res; 2020 Dec; 184():104955. PubMed ID: 33091434
[TBL] [Abstract][Full Text] [Related]
16. Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture.
Bakovic A; Risner K; Bhalla N; Alem F; Chang TL; Weston WK; Harness JA; Narayanan A
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572467
[TBL] [Abstract][Full Text] [Related]
17. Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection.
Monteil V; Dyczynski M; Lauschke VM; Kwon H; Wirnsberger G; Youhanna S; Zhang H; Slutsky AS; Hurtado Del Pozo C; Horn M; Montserrat N; Penninger JM; Mirazimi A
EMBO Mol Med; 2021 Jan; 13(1):e13426. PubMed ID: 33179852
[TBL] [Abstract][Full Text] [Related]
18. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
19. Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta.
Nair MS; Huang Y; Fidock DA; Towler MJ; Weathers PJ
J Ethnopharmacol; 2022 Feb; 284():114797. PubMed ID: 34737005
[TBL] [Abstract][Full Text] [Related]
20. Antiviral Activity of the Propylamylatin
Brown AN; Strobel G; Hanrahan KC; Sears J
Viruses; 2021 Mar; 13(3):. PubMed ID: 33807769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]